(Q2178381)

parenteral route of administration

17 November 2015

4.5 microgram

route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=B03XA02

active ingredient in

Aranesp

1 reference

European Medicines Agency product number

EMEA/H/C/000332

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000332/human_med_000651.jsp

European Medicines Agency product number

22 March 2017

Nespo

1 reference

EMEA/H/C/000333

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000333/human_med_000923.jsp

World Health Organisation international non-proprietary name

22 March 2017

Darbepoetin alfa (English)

1 reference

Darbepoetin alfa (English)

physically interacts with

19 January 2016

Erythropoietin receptor

subject has role

agonist

1 reference

stated in

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL1201566

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category B3

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

1 reference

Darbepoetin alfa (English)

stated in

DrugBank

17 November 2015

1 reference

Medical Subject Headings

MeSH descriptor ID

D000068256

15 March 2018

Identifiers

0 references

1 reference

ChEBI release 2019-10-02

1 reference

Darbepoetin alfa (English)

19 January 2016

0 references

1 reference

Guide to Pharmacology Ligand ID

Darbepoetin alfa (English)

publication date

17 November 2015

0 references

Darbepoetin alfa

0 references

MeSH tree code

D12.776.395.240.150.500

0 references

0 references

1 reference